Zynex has announced it received FDA clearance for a new device used primarily for treating female urinary incontinence, according to a news release.
The InWave medical device will be manufactured, marketed and sold through the company's Zynex Medical subsidiary.
"We are very excited about the introduction of this new product," said Thomas Sandgaard, CEO of Zynex, in the release. "The InWave adds to our already broad product line and is reimbursed by health insurance. We believe it will provide our expanding sales force an additional tool to fuel revenue generation in our rapid growing Zynex Medical subsidiary."
Zynex is headquartered in Lone Tree, Colo.
Related Articles on FDA Clearances:
AngioDynamics receives FDA Clearance for Peripherally Inserted Central Catheter
Symmetry Medical Receives FDA Clearance for FLASH PAK Evolution Valve
Covidien Receives FDA Clearance for Stapling System